2026년 10월 17일
FDA PDUFA target action date for phentolamine ophthalmic solution 0.75%, a NDA from Opus Genetics and Viatris. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
FDA PDUFA 결정 날짜 캘린더